ChosenMed
ChosenMed Technology, founded in 2017, is a precision oncology company leveraging next-generation sequencing and advanced data mining technologies. It integrates gene testing and artificial intelligence to develop and iteratively upgrade diagnostic products in the tumor liquid biopsy field. Its business covers multiple application scenarios including early tumor screening, companion diagnostics, dynamic monitoring, and prognosis evaluation. The company also explores tumor baselines and specific biomarkers in the Chinese population to support anti-tumor drug development. ChosenMed offers comprehensive solutions such as tumor clinical testing, early tumor screening kits, and one-stop high-throughput automated hospital solutions, positioning itself as a leader in China's precision oncology industry with extensive clinical collaborations and recognized certifications.
ChosenMed
ChosenMed Technology, founded in 2017, is a precision oncology company leveraging next-generation sequencing and advanced data mining technologies. It integrates gene testing and artificial intelligence to develop and iteratively upgrade diagnostic products in the tumor liquid biopsy field. Its business covers multiple application scenarios including early tumor screening, companion diagnostics, dynamic monitoring, and prognosis evaluation. The company also explores tumor baselines and specific biomarkers in the Chinese population to support anti-tumor drug development. ChosenMed offers comprehensive solutions such as tumor clinical testing, early tumor screening kits, and one-stop high-throughput automated hospital solutions, positioning itself as a leader in China's precision oncology industry with extensive clinical collaborations and recognized certifications.